ID   3A2D3
AC   CVCL_B0H7
DR   ABCD; ABCD_AI190
DR   ATCC; PTA-2849
DR   Wikidata; Q108819576
RX   Patent=US6291652;
RX   PubMed=22037470;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-2849.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P42858; Human HTT (Note=Recognizes expanded poly-Gln region).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 4
//
RX   Patent=US6291652;
RA   Finkbeiner S.;
RT   "Antibodies specific for proteins having polyglutamine expansions.";
RL   Patent number US6291652, 19-Sep-2001.
//
RX   PubMed=22037470; DOI=10.1038/nchembio.694;
RA   Miller J., Arrasate M., Brooks E., Libeu C.P., Legleiter J.,
RA   Hatters D., Curtis J., Cheung K., Krishnan P., Mitra S., Widjaja K.,
RA   Shaby B.A., Lotz G.P., Newhouse Y., Mitchell E.J., Osmand A., Gray M.,
RA   Thulasiramin V., Saudou F., Segal M., Yang X.W., Masliah E.,
RA   Thompson L.M., Muchowski P.J., Weisgraber K.H., Finkbeiner S.;
RT   "Identifying polyglutamine protein species in situ that best predict
RT   neurodegeneration.";
RL   Nat. Chem. Biol. 7:925-934(2011).
//